tetano
Editor, Senior Moderator
J Clin Virol. 2011 Dec 14. [Epub ahead of print]
Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.
G?ria MT, Rebelo de Andrade H, Santos LA, Correia VM, Pedro SV, Santos MA.
Source
CPM-URIA, Faculdade de Farm?cia da Universidade de Lisboa, Lisboa, Portugal.
Abstract
BACKGROUND:
Genetic changes in influenza surface and internal genes can alter viral fitness and virulence. Mutation trend analysis and antiviral drug susceptibility profiling of A(H1N1)pdm09 viruses is essential for risk assessment of emergent strains and disease management.
OBJECTIVE:
To profile genomic signatures and antiviral drug resistance of A(H1N1)pdm09 viruses and to discuss the potential role of mutated residues in human host adaptation and virulence.
STUDY DESIGN:
A(H1N1)pdm09 viruses circulating in Portugal during pandemic and post-pandemic periods and 2009/2010 season. Viruses were isolated in MDCK-SIAT1 cell culture and subjected to mutation analysis of surface and internal proteins, and to antiviral drug susceptibility profiling.
RESULTS:
The A(H1N1)pdm09 strains circulating during the epidemic period in Portugal were resistant to amantadine. The majority of the strains were found to be susceptible to oseltamivir and zanamivir, with five outliers to neuraminidase inhibitors (NAIs) identified. Specific mutation patterns were detected within the functional domains of internal proteins PB2, PB1, PA, NP, NS1, M1 and NS2/NEP, which were common to all isolates and also some cluster-specific.
DISCUSSION:
Modification of viral genome transcription, replication and apoptosis kinetics, changes in antigenicity and antiviral drug susceptibility are known determinants of virulence. We report several point mutations with putative roles in viral fitness and virulence, and discuss their potential to result in more virulent phenotypes. Monitoring of specific mutations and genetic patterns in influenza viral genes is essential for risk assessing emergent strains, disease epidemiology and public health implications.
Copyright ? 2011 Elsevier B.V. All rights reserved.
PMID:
22177272
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22177272
Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.
G?ria MT, Rebelo de Andrade H, Santos LA, Correia VM, Pedro SV, Santos MA.
Source
CPM-URIA, Faculdade de Farm?cia da Universidade de Lisboa, Lisboa, Portugal.
Abstract
BACKGROUND:
Genetic changes in influenza surface and internal genes can alter viral fitness and virulence. Mutation trend analysis and antiviral drug susceptibility profiling of A(H1N1)pdm09 viruses is essential for risk assessment of emergent strains and disease management.
OBJECTIVE:
To profile genomic signatures and antiviral drug resistance of A(H1N1)pdm09 viruses and to discuss the potential role of mutated residues in human host adaptation and virulence.
STUDY DESIGN:
A(H1N1)pdm09 viruses circulating in Portugal during pandemic and post-pandemic periods and 2009/2010 season. Viruses were isolated in MDCK-SIAT1 cell culture and subjected to mutation analysis of surface and internal proteins, and to antiviral drug susceptibility profiling.
RESULTS:
The A(H1N1)pdm09 strains circulating during the epidemic period in Portugal were resistant to amantadine. The majority of the strains were found to be susceptible to oseltamivir and zanamivir, with five outliers to neuraminidase inhibitors (NAIs) identified. Specific mutation patterns were detected within the functional domains of internal proteins PB2, PB1, PA, NP, NS1, M1 and NS2/NEP, which were common to all isolates and also some cluster-specific.
DISCUSSION:
Modification of viral genome transcription, replication and apoptosis kinetics, changes in antigenicity and antiviral drug susceptibility are known determinants of virulence. We report several point mutations with putative roles in viral fitness and virulence, and discuss their potential to result in more virulent phenotypes. Monitoring of specific mutations and genetic patterns in influenza viral genes is essential for risk assessing emergent strains, disease epidemiology and public health implications.
Copyright ? 2011 Elsevier B.V. All rights reserved.
PMID:
22177272
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22177272